SLC6A3 and attention deficit-hyperactivity disorder: In another in vitro study of two DAT1 mutations found in an adult patient with comorbid Parkinson’s disease and ADHD, the DAT1 I312D mutation was associated with significantly lower maximal velocity of dopamine influx but no difference in overall DAT protein expression as well [126].